Abstract
Internal organs heal injuries with new connective tissue, but the cellular and molecular events of this process remain obscure. By tagging extracellular matrix around the mesothelium lining in mouse peritoneum, liver and cecum, here we show that preexisting matrix was transferred across organs into wounds in various injury models. Using proteomics, genetic lineage-tracing and selective injury in juxtaposed organs, we found that the tissue of origin for the transferred matrix likely dictated the scarring or regeneration of the healing tissue. Single-cell RNA sequencing and genetic and chemical screens indicated that the preexisting matrix was transferred by neutrophils dependent on the HSF–integrin AM/B2-kindlin3 cascade. Pharmacologic inhibition of this axis prevented matrix transfer and the formation of peritoneal adhesions. Matrix transfer was thus an early event of wound repair and provides a therapeutic window to dampen scaring across a range of conditions.
Subject terms: Neutrophils, Proteasome
Rinkevich and colleagues show that preexisting matrix is transferred by neutrophils across organs into injured sites in a manner dependent on integrin activation.
Main
Injured tissues are replaced by rigid anatomies through accrual of extracellular matrix. These rigid structural and mechanical continuums allow survival of the organism. When normal repair fails, the result is either non-healing chronic wounds or aggravated scarring and fibrosis1–3. Impaired healing and excessive scarring are a tremendous burden for people and for the global healthcare system4,5. Understanding the repair process and the connective tissue (matrix) accrual is therefore critical to restore and preserve the normal functions of injured adult organs. The primary agents of connective tissue accrual are the fibroblasts, which communicate with other cell types6–11. Connective tissue accrual is thought to ensue when a specialized population of fibroblasts migrates into the wound bed to locally synthesize and deposit matrix at sites of injury.
Here we explored the provenance of connective tissue accrual in internal wounds by tagging the preexisting connective tissues underneath the mesothelium surrounding the peritoneum, liver and cecum in mice and following the accumulation of matrix in laparotomy closures, brushing of organ surfaces, ischemic pockets, lipopolysaccharide (LPS) injections and liver electroporations. We found that injury triggered whole-organ mobilization of connective tissue matrix that accrued in wounds and fueled fibroblast activation and scar formation.
Results
Preexisting matrix is transferred across organs to seed wounds
Because loose connective tissue (matrix) serves as the major source for dermal scars in skin12, we investigated the involvement of preexisting matrix in internal organ injury. For this, we locally tagged and fate-mapped the matrix lining the organ surfaces of live mice using a nontoxic N-hydroxysuccinimide ester fluorescein (NHS-FITC) (Extended Data Fig. 1a). NHS-FITC labeling did not induce cell death or immune cell recruitment at steady state (Extended Data Fig. 1b,c) and the NHS-FITC+ matrix remained stationary over 24 hours in healthy livers of adult mice (Fig. 1a). To test the mobility of the matrix during injury, we used a wound model based on irreversible electroporation, which is used to operate in various tumor settings. Electroporation kills hepatocytes, and the consequent repair response regenerates without scar tissue13–15. We marked the matrix at six distinct locations across the liver, creating circular patches of NHS-FITC+ matrix with clearly defined boundaries that remained stationary in the absence of a secondary injury (Fig. 1a). When a seperate, non-labeled liver location was damaged by electroporation, pools of NHS-FITC+ matrix from all six labeled sites moved from their original location into the injury site within 24 hours postinjury (p.i.), completely filling the wound (Fig. 1a). Three-dimensional imaging of the wounds at 24 hours p.i. showed that the transferred NHS-FITC+ matrix within the wound was structurally distinct from the matrix rigid frames formed by second harmonic generating (SHG) matrix structures (Fig. 1b). At the extremities of the wound, the transferred NHS-FITC+ matrix protruded into filaments that adhered to and wrapped around the SHG+ rigid matrix frames, and interconnected with the adjacent healthy connective tissue (Supplementary Movie 1). Notably, unlabeled, injured surfaces lacked fluorescence (Extended Data Fig. 1d), excluding the possibility of autofluorescence as signal artifacts. These observations indicated that liver injury induced organ-wide transfer of matrix towards the injury site. To test whether transfer of matrix was detected in other organs, we also looked in the peritoneum. Circular regions of peritoneal matrix were labeled with NHS-FITC, and local injury was induced by brushing a nearby area (Fig. 1c). NHS-FITC+ matrix transferred into wounds as early as 30 minutes p.i. In a third injury model, peritonea were injured by clinical incision (laparotomy), followed directly by NHS-FITC labeling of six distinct regions of peritoneal matrix (Fig. 1d). At 24 hours p.i., the incision sites were completely occluded with transferred NHS-FITC+ matrix (Supplementary Movie 2)
Next, we tracked the kinetics of matrix transfer at 24 hours, 72 hours and 2 weeks following liver and peritoneal tissue injury by quantifying the NHS-FITC+ matrix in the injured sites compared with unwounded tissue that acted as a control. NHS-FITC+ matrix from the labeled patches expatriated continuously for 2 weeks (Fig. 1e), while the amount of NHS-FITC+ matrix increased incrementally in both the liver and peritoneum wounds (Fig. 1f), indicating that matrix transfer contributed to formation of new tissue and subsequent remodeling. Multiphoton microscopy showed that NHS-FITC+ matrix had crosslinked into mature fibrillar connective tissue that patched wounds with scars in peritoneas (Fig. 1g) and livers (Extended Data Fig. 1e) at week 2 p.i. (Supplementary Movies 3–5).
To quantify the ratio of transferred to de-novo-synthesized matrix in wounds, we intraperitoneally (i.p.) injected the non-canonical amino acids (ncAAs) alanine (azidohomoalanine) and glycine (homopropargylglycine), which are randomly integrated into all newly synthesized proteins, including ECM, and can be detected and quantified using simple click chemistry16, into mice 2 hours before liver and peritoneum injury, directly followed by NHS-FITC labeling of specific liver and peritoneum patches and daily ncAAs injections (Extended Data Fig. 2a). At 72 hours, the ncAAs signal in the muscle tissue acted as control. Robust integration and massive influx of ncAAs– NHS-FITC+ matrix was detected in peritoneal wounds, and staining with an antibody to PDGFR, a marker of fibroblastic cells, did not detect active fibroblasts (Extended Data Fig. 2a), indicating absent or marginal synthesis of new ECM at this time point. Significant amounts of PDGFR+ fibroblasts could be detected at week 2 p.i. (Extended Data Fig. 2b), and newly deposited ncAAs+ ECM was woven into and integrated into the transferred NHS-FITC+ matrix at this time point (Extended Data Fig. 2b).
Large numbers of PDGFR+ cells are detected in the liver during homeostasis17. Although electroporation increased the number of PDGFR+ fibroblasts in liver wounds at day 3 and week 2 p.i. (Extended Data Fig. 2c–e), injury resulted in the regeneration of the connective tissue, rather than the formation of the fibrotic scars seen in laparotomy closures (Extended Data Fig. 2b). Collagen type 1 staining indicated that the NHS-FITC+ matrix accounted for 80% of the collagen type 1 protein in healed liver and peritoneal wounds, whereas NHS-FITC− collagen accounted for only 20% (Fig. 1g). These experiments indicate that matrix accrual initiated from transferred matrix, and this was gradually remodeled with de-novo-synthesized matrix over time.
Transferred matrix regenerates connective tissue in wounds
Next, to investigate how transferred matrix was crosslinked into fibrils in the wound during repair, we labeled live mouse liver surfaces at two distinct locations, one with NHS-EZ-LINK-Biotin and the other with NHS-FITC-ester. After detergent-rich washes to remove fragile interactions, we purified and quantified crosslinked proteins on streptavidin beads. We detected a steady increase in NHS-FITC in the pulldown samples from wounds at 2, 6, 24 and 72 hours p.i. (Fig. 2a), indicating that matrix that originated at distinct organ sites was crosslinked into the repairing wounds to form mature, stably interconnected matrix.
Next, to investigate the distance over which matrix could be transferred, we used a surgical adhesion model in which local abrasion of peritoneal and cecal organ surfaces results in fibrous adhesions between them at 4 weeks p.i. Nearby labeling of the peritoneum (with NHS-FITC) and cecum (with NHS-AF568) indicated cecal and peritoneal matrix intermixing at the injury site, where bands of fibrous adhesions developed 4 weeks p.i. (Fig. 2c). At 2 weeks p.i., pulled-down wound lysates (performed as above) contained abundant NHS-FITC+ cecal and NHS-EZ-LINK+ peritoneal proteins (Fig. 2d), indicating that abundant crosslinking had occurred between cecal and peritoneal matrix elements.
To test whether matrix transferred between the peritoneum and liver, we induced adhesion between these two organs by local abrasion of the peritoneum and liver electroporation. We detected transfer and intermixing of NHS-FITC+ peritoneal and AF568+ liver matrix at adhesion sites at 4 weeks p.i. (Fig. 2e). Peritoneal-derived NHS-FITC+ matrix transferred into liver wounds, whereas liver AF568+ matrix was not detected in the peritoneal wounds (Fig. 2e), indicating that fibrous adhesions and scars originated from the peritoneal but not from the transferred liver matrix (Fig. 2e and Supplementary Movie 6). In injuries induced across two opposite liver lobes, one pre-labeled with NHS-FITC and the other with NHS-PB, we did not detect intermixing of labels or the formation of fibrous adhesions between the lobes at 4 weeks p.i. (Fig. 2f), indicating that only the peritoneal matrix had the ability to form stable scars remotely. Our data suggest that organ-specific matrices formed fibrous adhesions by crosslinking events.
Transferred matrix predetermines tissue repair outcomes
Next, we used mass spectrometry to determine the protein constituents of the transferred matrix. We tagged pools of matrix with modified biotin-conjugated EZ-LINK sulfo-NHS esters in the liver, peritoneum and cecum and induced injury at sites distinct from the labeled patches. Twenty-four hours p.i., we collected matrix from the wounds and the labeled sites, purified the EZ-LINK+ matrix proteins through streptavidin pulldown and performed proteomics of all tagged peptides. We detected hundreds of ECM proteins that represented components of adventitial and serosal connective tissue layers (Extended Data Fig. 3a and Supplementary Tables 2–4) and that could be classified as collagens, ECM glycoproteins, ECM regulators, ECM-affiliated proteins, proteoglycans and secreted factors18. The total matrix pools had a different composition in the liver, peritoneum and cecum, and these organ-specific matrix compositions appeared both in the labeled sites and in the wounds (Fig. 3a). The peritoneum was characterized by higher amounts of collagen, liver had more abundant ECM regulators and the cecal matrix had increased amounts of secreted protein factors (Fig. 3a). We detected abundant fibrillar collagenous fiber proteins, such as collagen type I and III and their crosslinking enzymes, including lysyl oxidase and transglutaminases, which are involved in connective tissue remodeling and maturation (Fig. 3b); proteins involved in basement-membrane formation and stability, such as collagen type IV and VI, including laminins; and elastic fibers (Fig. 3b). This protein inventory contributed to tissue remodeling, fiber clot formation, fibrinolysis, granulation and scar-tissue formation (Fig. 3b).
Principal component analysis of sample distribution indicated that the composition of the transferred matrix was organ-specific, enriched for either scarless repair in liver or scarring and fibrosis in the peritoneum (Fig. 3c). For example, transferred NHS-EZ-LINK+ liver matrix was enriched in regulators of scarless tissue repair, such as Ambp, Itih1, Kng1 and PZP (Fig. 3d), all of which support cellular growth and repair, as well as regulators of oxidative stress, metabolic enzymes and lipid metabolism (Fig. 3d). The NHS-EZ-LINK+ matrix that had originated from the peritoneum was profibrotic and was enriched in collagenous fibers and ECM glycoproteins that induce connective tissue organization, maturation and scar formation (Fig. 3c), including collagen types IX, X and XI, and chaperones of fibrotic scar formation, such as Grem1, Ogn, Chad, MMP9 and MMP20 (Fig. 3). These proteins were completely absent from the liver matrix (Fig. 3e).
To investigate whether these findings translate to humans, we took samples from people of different ages and sexes (n = 10) who had developed postoperative adhesions between different abdominal organs, and we used immunofluorescence to determine the protein composition of these adhesions. We detected the same adventitial protein elements found in the mouse peritoneal matrix, such as Lam, Col4, FBN and HSPG2 (Extended Data Fig. 3b), suggesting that human wound repair mobilized matrix from remote adventitial and serosa sites, as in mice. These analyses suggest that the precise protein repertoire in each organ dictated the ensuing repair response, whether scarless or scarring.
Transferred matrix originates in the mesothelium
Next, to identify the cellular source of the transferred matrix, we virally transfected an area on the surface of peritoneum or liver with a native collagen 1-binding protein reporter (CNA35) fused to mCherry fluorescent protein (CNA35-mCherry) (Extended Data Fig. 4a). In this reporter system, transduced cells incorporate Col1CNA35-mCherry in the collagen helices and enable real-time visualization and quantification of collagen deposition in live tissues19. Five days after viral transduction, we labeled the same area of the matrix with NHS-FITC, and subjected remote, non-transduced and non-tagged areas to wounding. Light-sheet images (Extended Data Fig. 4b and Supplementary Movie 7) and histology sections (Extended Data Fig. 4c) of the wounded areas indicated extensive accumulation of CNA35-mCherry+NHS-FITC+ matrix in the wounds 24 hours p.i. CNA35-mCherry+NHS-FITC+ matrix made up to 70% and 80% of total collagen in peritoneal and liver wounds, respectively (Extended Data Fig. 4d). Immunohistochemistry staining of the labeled site at week 1 p.i. showed significant amounts of PDPN+ mesothelial cells expressed phosphorylated SMAD2 and SMAD3, indicative of active TGF-β signaling, compared with at 24 hours p.i. (Extended Data Fig. 4e). These experiments indicated that mesothelium was the source of the matrix that was transferred into the wounds.
In skin, a specialized population of En1-lineage positive fibroblasts (EPFs) repairs deep skin wounds by mobilizing distal fascia connective tissue, and mobilization occurs through a collective cell migration that is dependent on N-cadherin in a swarm-like behavior mediated by cell-to-cell contact12,20. To explore whether internal organs transferred matrix in a similar way, we labeled and injured peritoneal and liver surfaces as above, and stained wounds at day 1 p.i. with the fibroblast markers PDGFR and NCAD, as well as the neutrophil marker Ly6G. We detected minimal PDGFR+ fibroblasts or N-cadherin expression, and the accumulation of Ly6G+ myeloid cells in wounds (Extended Data Fig. 5a), suggesting fibroblasts were not involved in the transfer of matrix in the liver and peritoneum. To further test this, we used En1CreR26mTmG mice, in which all fascia fibroblasts are GFP+. At 24 hours following liver and peritoneal injuries in the En1CreR26mTmG mice, we did not detect scar-forming GFP+ EPFs in or around the wounds, although we could detect transferred NHS-AF647+ matrix (Extended Data Fig. 5b), suggesting that matrix transfer in liver and the peritoneum was different from the fibroblast-dependent matrix transfer in the skin. Next, we performed liver and peritoneal injuries in C57BL/6J wild-type mice injected with exherin, a blocking peptide that inhibits N-cadherin and blocks fibroblast and fascia movements in skin20. N-cadherin blocking had no effect on the transfer of matrix or wound healing in liver or peritoneum at 24 hours p.i. (Extended Data Fig. 5c). These observations suggest that fibroblasts were not involved in the transfer of matrix to wounds in these internal organs.
Neutrophils carry fibrotic matrix into wounds
To investigate the link between matrix transfer and inflammation, both of which occur during the early phases of the repair response, we i.p. injected LPS, which is known to induce inflammation-driven fibrosis21, in mice with local peritoneal and cecal NHS-FITC labeling. Seven days post-LPS injection, we detected massive amounts of NHS-FITC+ matrix within the fibrotic sites in the peritoneum and cecum, compared with in mice injected with PBS as control (Extended Data Fig. 6), indicating matrix mobilization occured during sterile inflammation. To investigate the role for myeloid cells in the transfer of matrix, we used Lyz2-Cre Ai14 transgenic mice, in which the tdTomato fluorescent protein is expressed in all cells in the myeloid lineage. Live imaging of liver and peritoneal wounds in Lyz2-Cre Ai14 mice with remote NHS-FITC labeling indicated that tdTomato+ myeloid cells accumulated in wounds at 24 hours p.i. by migrating across large sweeps of organ surfaces (Fig. 4a). We found most, if not all, tdTomato+ myeloid cells (~90%) that migrated from the NHS-FIT-labeled site carried fragments of NHS-FITC+ matrix across organ surfaces (Supplementary Movies 8 and 9). tdTomato+ myeloid cells carrying NHS-FITC+ matrix had no cytoplasmic overlap of the red and green signal (Fig. 4b), suggesting that myeloid cells did not synthesize or phagocytose the matrix. We found NHS-FITC+ matrix was associated with individual tdTomato+ myeloid cells, but also with groups of tdTomato+ myeloid cells that clumped in foci near the wound (Supplementary Movies 10 and 11). These foci contained swarms of active neutrophils, as indicated by staining for CD63, CD66b, FPR1 and TNF receptor (Fig. 4c). Depletion of neutrophils by injection of a Ly6g-neutralizing antibody completely blocked the transfer of NHS-FITC+ matrix in wounds (Fig. 4d), whereas chemical depletion of macrophages with clodronate had no significant effect on matrix transfer (Fig. 4d).
To test whether neutrophils transferred matrix by mediating protease-dependent tissue permeability22,23, we performed matrix fate mapping in C57BL/6J wild-type mice injected i.p. with inhibitors of aminopeptidase, cathepsin and metalloproteases 1–3, 7–9 and 12–14, all linked to neutrophil functions, or DMSO as control 2 hours before liver and peritoneal injury in conjunction with distant NHS-FITC labeling. Inhibitor treatment had no significant effect on the transfer of NHS-FITC+ matrix or accumulation of Ly6G+ cells in wounds 24 hours p.i. However, inhibition of elastase with either elastinal or elastase inhibitor II significantly increased FITC+ matrix transfer and Ly6G+ cell abundance in wounds compared with in DMSO-treated controls (Fig. 4e), indicating an inhibitory effect of elastases in neutrophil-dependent ECM transfer. In addition, high-resolution images did not detect interstitial or vascular neutrophils (Extended Data Fig. 7a), suggesting matrix transfer was independent of vascular permeability. We did not detect CD45+Ly6G+ circulating neutrophils associated with NHS-FITC+ material in the blood of experimental mice at 24 hours p.i (Extended Data Fig. 7b), indicating that transport of matrix occurred primarily within the interstitial spaces of injured organs. Transfer of NHS-FITC+ matrix into wounds still occurred in the presence of the collagen-synthesis inhibitors tranilast and halofuginone (Fig. 4f), further suggesting the transfer of pre-existent matrix. Neutrophils can modulate fibroblasts to deposit matrix or can degranulate24,25, and as such contribute to the synthesis of matrix in wounds. However, matrix transfer was independent of neutrophil protein synthesis or degranulation (Fig. 5e,f). Neutrophil swarming and chemoattraction are coordinated through different pathways, triggered by leukotriene, lipoxin A4 and chemokines binding to the chemokine receptors CXCR2 and CXCR4, and nitric oxide26,27. Blocking or inhibition of CXCR2 and leukotriene receptor activity completely blocked the transfer of NHS-FITC+ matrix into wounds, whereas inhibition of CXCR4 had no significant effect (Fig. 4g). Local application of lipoxin A4 on liver surfaces induced the recruitment Ly6G+ neutrophils and the transfer of NHS-FITC+ matrix at 24 hours p.i., compared with PBS application in the absence of injury (Fig. 4h). Overall, these data indicate that neutrophils transferred preexisting matrix into the sites of injury.
Neutrophils use integrin Mβ2 to carry matrix into wounds
To further study the specific cells populating the wounds, we used highly parallel single-cell transcriptomics of 25,000 cells isolated at day 1 and day 7 p.i. from the wounds and uninjured control livers. This analysis differentiated 17 distinct immune cell populations within the wound (Fig. 5a,b), of which myeloid cells, such as monocytes and macrophages, represented the predominant lineage (55%) (Fig. 5a–c). Next, we determined the expression of membrane receptors that might enable the transport of extracellular matrix to wound sites in the myeloid, including neutrophil clusters (Fig. 5d). We noticed gene expression in neutrophils was altered during the liver injury response, with a significant upregulation of the integrin subunit αM (ITGAM) compared with in neutrophils from healthy tissue (Fig. 5e). Integrins ITGAM and ITGB2 heterodimerize to form αMβ2 (also known as Mac-1, CD11b/CD18 or CR3).
Analysis of inferred lineage relationships among neutrophils indicated that neutrophils displayed substantial heterogeneity between day 1 and day 7 in pairwise correlation of cells as well as in hierarchical clustering of genes. Particularly, at 24 hours p.i., increased expression of genes like CXCR4 or CD24a (Fig. 5f,g) indicated the gradual maturation and differentiation of neutrophils over time, while increased expression of apoptotic factors27 and age-related genes28 (Fig. 5h) indicated their activation in response to electroporation. Pseudotemporal positioning of neutrophils revealed a temporal sequence of gene regulatory events during neutrophil maturation, ending at 7 days p.i. with multiple end points indicative of diverse subpopulations (Fig. 5i,j), suggesting that neutrophils differentiated into defined subpopulations after injury within the wound, ultimately resulting in apoptosis.
Single-cell sequencing data showed there was no significant upregulation of matrix-associated genes in neutrophils during liver injury (Fig. 5k,l), indicating that neutrophils do not synthesize matrix. Immunolabeling in C57BL/6J wild-type mice detected the upregulation of ITGAM and ITGB2 on neutrophils in peritoneal and liver wounds at 24 hours p.i. (Fig. 6a). I.p. injections with neutralizing antibodies against ITGAM and ITGB2 2 hours before matrix labeling in C57BL/6J mice led to a reduction or complete cessation of NHS-FITC+ matrix transfer in the wound at 24 hours p.i. compared with a control antibody (Fig. 6b), indicating that matrix transfer was dependent on integrin activation. Although transferred FITC+ matrix could not be detected after αMβ2 blocking, Ly6G+ neutrophils were still present in the wounds of these mices compared with those that received control antibody injections (Fig. 6b), suggesting that integrin blocking inhibited matrix transport, and not neutrophil migration, extravasation or crawling into wounds.
Kindlin3 is an essential component of integrin-mediated focal adhesions that form between cells and the extracellular matrix28,29.To explore how integrin-dependent signaling in neutrophils regulated matrix transfer, we used R26CreERKindlin3fl/fl mice, in which the integrin signaling-mediator kindlin3 can be conditionally deleted by administration of tamoxifen, resulting in a block in integrin signal transduction. To address whether matrix transfer into wounds depended on intact integrin signaling (that is, intact kindlin3 expression), we adoptively transferred neutrophils from tamoxifen-treated R26CreERKindlin3fl/fl mice (kindlin3− neutrophils) and control R26CreER-negativeKindlin3fl/fl mice (kindlin3+ neutrophils) into wild-type mice in which neutrophils had been depleted by intravenous injection of Ly6G antibodies, followed by liver and peritoneal injury after neutrophil reconstitution (Fig. 6c). NHS-FITC+ matrix was not detected in the wounds of Ly6G antibody-treated mice in the absence of neutrophil reconstitution (Fig. 6c), but accumulated in mice reconstituted with kindlin3+ neutrophils (Fig. 6c). Transferred Ly6G+kindlin3− neutrophils were detected in wounds in large numbers at 24 hours p.i., but NHS-FITC+ matrix was not detected (Fig. 6c). Thus, integrin signaling in neutrophils was required for matrix transfer into wounds.
Neutrophilic response to injury is HSF dependent
To establish the upstream signals of matrix transfer into wounds, we investigated the role of ‘heat shock’ signaling, which is a known pharmacological target in fibrosis30,31 and has been shown to regulate integrin function32,33. I.p. injection of the heat shock factor (HSF) inhibitors HSI and KRIBB11 2 hours before injury blocked NHS-FITC+ matrix accumulation 24 hours p.i. in liver and peritoneal wounds to the same extent as neutrophil depletion or integrin signaling inhibition in kindlin3− neutrophils (Fig. 7a). Next, we asked whether heat shock signaling controlled integrin activation in neutrophils. αMβ2 heterodimerization is a critical stage in integrin activation20. More ITGB2 immunoprecipitated with ITGAM in lysates of wound-derived neutrophils 24 hours p.i. compared with blood neutrophils from non-wounded mice (Fig. 7b). Moreover, injection of HSI and KRIBB11 decreased αMβ2 immunoprecipitated in wound-derived neutrophils (Fig. 7b), indicating heat shock proteins induce heterodimerization.
To investigate the clinical role of HSF in wound response, we took peritoneal biopsies from R26CreERKindlin3fl/fl mice, labeled the ECM ex vivo with NHS-FITC and cultured these tissues for 24 hours with neutrophils pretreated with HSF inhibitor 1 or DMSO as control (Extended Data Fig. 8a). NHS-FITC+ matrix transfer was not observed in tissues cultured with HSF inhibitor1-treated neutrophils, in contrast with DMSO-treated neutrophils (Extended Data Fig. 8a). Next we intraperitoneally transferred neutrophils pretreated with HSF inhibitor 1 or DMSO into tamoxifen-treated R26CreERKindlin3fl/fl (Kindlin3 cKO) mice directly after matrix tagging and peritoneal or liver injury. Both DMSO- and HSF-inhibitor-1-treated Ly6G+ neutrophils were detected in wounds 24 hours p.i. (Fig. 7c). However, NHS-FITC+ matrix was only transferred in Kindlin3 cKO mice reconstituted with DMSO-treated neutrophils (Fig. 7c).
We investigated whether heat shock protein inhibition could be used as a pharmacological intervention against matrix transfer and peritoneal adhesions (scars). We induced surgical adhesions between peritoneum and cecum and applied a single dose of 10 nM HSI or DMSO i.p. We detected transfer of NHS-FITC+ matrix into sites of adhesion as early as 24 hours p.i. in mice treated with DMSO, but not with in mice treated with HSI (Fig. 7d). Four weeks p.i., peritoneal adhesions in mice treated with DMSO were filled with a foundation of NHS-FITC+ collagen I protein (Fig. 7d), indicating that it originated in remote locations. In the presence of transferred NHS-FITC+ matrix, peritoneal adhesions incorporated active PDGFR+YAP/TAZ+ fibroblasts and pSMAD2/3+PDPN+ mesothelial cells (Fig. 7d), indicative of remodeling and maturation and mature long-lasting adhesions. Conversely, application of HSI completely blocked the transfer of NHS-FITC+ matrix (Fig. 7d), while scars and long-lasting adhesions failed to form by 4 weeks p.i., without detectable impairment of wound closure or healing (Fig. 7d). These results indicate the therapeutic potential of blocking HSF-integrant signaling in order to prevent matrix transfer, scars and peritoneal adhesions in mice.
Discussion
Here we show that organ connective tissues contained mobile matrix reservoirs, and that injury triggered organ-wide transfer of this preexisting matrix into injured tissue, where they fueled tissue repair. Premade connective tissue matrix moved from the mesothelial layer surrounding visceral and parietal internal organs, across the organ, into injured sites. This immature proteinaceous matrix was crosslinked to reestablish rigid connective tissue frames to repair breaches in liver or peritoneum. We found that neutrophils had an essential role in transferring matrix into wounds through heat shock–integrin signaling.
Although our results indicated that mesothelium exported bulk connective tissue into wounds, this is not mutually exclusive to the prevailing view that fibroblasts deposit matrix to further consolidate scars over extended periods of time in response to a much stiffened and biomechanically altered wounded microenvironment34. We have demonstrated here that this altered biomechanical, physical and signaling scar environment was likely provided by imported matrix. Indeed, we have shown that in the absence of matrix transfer, wounds failed to incorporate active fibroblasts or to mature into long-lasting scars. Fibroblasts are therefore part of a secondary response to the initial scar-formation process launched by matrix transfer.
We found that matrix transportation was not exclusive to organ surfaces but could happen in deep interstitial tissue once a deeper incision was made. We speculate that matrix transportation may play a much broader role in wound repair and fibrosis beyond organ surfaces. Importantly, we found around 80% of scar tissue came from distal mobil matrix reservoirs.
Our proteomic data from the mesothelial matrix material transferred into wounds leads us to speculate that the specific protein composition of the transferred matrix, rather than the organ fibroblasts, determine the diverging fibrotic responses that develop during adult tissue repair. Indeed, the repertoire of transferred matrix elements varied between peritoneum, cecum and liver. In the mesothelial lining of the liver, the transferred matrix contained many enzymes and pro-regeneration proteins and injuries that transferred matrix across adjacent liver lobes after injury, leading to scarless repair without fibrous adhesions between the opposing lobes. The idea that preexisting matrix contributes to wound repair was demonstrated by juxtaposing liver and non-regenerating peritoneal tissue and injuring the interface locally. When injured liver was in direct proximity to injured peritoneum surfaces, peritoneal matrix was transferred on the liver, initiating fibrous adhesions and scars between liver and peritoneum.
Understanding the molecular choreography that moves matrix into wounds provides multiple opportunities for therapeutic intervention. Using time-lapse video, we showed that, at 24 hours p.i., tissue repair was directed by neutrophils, which steered mesothelial matrix into tissue-repair sites within minutes. Neutrophils upregulated the collagen-binding integrins αMβ2, which heterodimerized to transfer matrix downstream of HSF signaling.
A link between integrins, kindlin3 and various developmental and wound-healing processes also exists in humans. Leukocyte adhesion deficiency type III (LADIII) is a disorder characterized by dysfunctional kindlin3 activity. People with LADIII syndrome have abnormal bone structure, uncontrollable bleeding and impaired wound healing35, which is associated with connective tissue deposition. As matrix transport was dependent on kindlin3, we speculate that the LADIII-associated phenotypes may be linked with impaired matrix transport.
Neutrophils have an important and early role in early adhesion formation, primarily through neutrophil extracellular trap (NET) secretion36. Here we showed that neutrophils provided the components necessary for fibrotic scar tissue. Transcriptionally distinct neutrophil subpopulations can be distinguished in terms of their maturity and distinct functions37. Our analysis did not indicate which distinct population of neutrophils contributed to matrix transport. However, the scRNA-seq data suggested that the matrix movement was accomplished by neutrophils that activated HSF, upregulated ITGAM and ITGβ2, and homed towards wounds through CXCR2, NOS and LTB4R chemoattraction. Once in the wounds, neutrophils underwent further maturation, ending in apoptosis. The exact half-life of neutrophils is still unclear, but recent methods estimate that it is between 6 and 12 hours38. Because matrix transport continued for several days and reached a plateau at about 72 hours, we assume that new neutrophils are constantly migrating into the wound during the process. While our scRNA-seq data indicated that different subpopulations of neutrophils entered the wound, future studies are needed to refine which subsets of neutrophils enable matrix transport, or whether matrix transport is universal to all mature subsets. Expression of ITGβ2 on neutrophils seemed to be necessary for matrix transport, but not for the physical relocation of neutrophils into wounds, as ITGβ2 blocking affected matrix cargo, but did not block neutrophil recruitments into wounds. Once transported into wounds, matrix served as a provisional wound material, where it was further crosslinked covalently to other matrix elements. We also found that, as matrix was moved into wounds from remote organ locations, mesothelial cells initiated de novo synthesis of ECM, and replenished matrix pools within the organ.
Heat shock signaling regulates wound healing, presumably through reducing TGF-β signaling and the differentiation of fibroblasts39–41. Our data indicate that the HSF–integrin axis acted in neutrophils to transfer matrix into wounds. Moreover, heat shock factors acted as potential pharmacologic targets by blocking matrix seeding in wounds. Modulation of matrix transfer by heat shock factors in neutrophils during early wound repair creates a new therapeutic space to treat impaired wounds and excessive scarring.
Methods
Animals
All mouse lines (C57BL/6J, B6.129P2-Lyz2tm1(cre)Ifo/J (Lyz2Cre), B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (Ai14)), En1Cre (En1tm2(cre)Wrst)R26mTmG (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) were obtained from Jackson Laboratories or Charles River. R26CreER;floxKindlin3flox mice were provided by P. K. and R. F. Animals were bred and maintained in the Helmholtz Animal Facility in accordance with EU directive 2010/63. Animals were housed in individual ventilated cages, and animal housing rooms were maintained at a constant temperature of 20–24 °C and humidity of 45–65% with a 12-hours light cycle and were supplied with water and chow ad libitum. All animal experiments were reviewed and approved by the Government of Upper Bavaria and registered under the project number ROB-55.2-2532.Vet_02-19-133 or ROB-2532.Vet_02-19-148 and conducted under strict governmental and international guidelines. This study is compliant with all relevant ethical regulations regarding animal research.
Injury models
Thirty minutes before surgery, mice received a preemptive subcutaneous injection of metamizole (200 mg/kg body weight). Anesthesia was supplied by an intraperitoneal injection of a medetomidine (500 μg/kg), midazolam (5 mg/kg) and fentanyl (50 μg/kg) cocktail, hereafter referred to as MMF. Anesthetic depth was assessed by toe reflex. Eyes were covered with bepanthen-cream to avoid dehydration, and the abdomen was shaved and disinfected with betadine and sterile PBS. Animals were kept on their backs on a heating plate at 39 °C. A midline laparotomy (1–1.5 cm) was performed through the skin and peritoneum. Four hooks, positioned around the incision and fixed to a retractor and magnetic base plate, allowed for clear access to the abdominal cavity and liver.
Local damage to the liver surface was induced via electroporation tweezers by applying 30-V, 50-ms pulses at 1-second intervals for 8 cycles. Before closure of the incision, buprenorphine (0.1 mg/kg) was pipetted in the abdomen to allow for initial postsurgical analgesia. For long-term analgesia, metamizole (novalgin, 200 mg/kg) was provided through daily injections. The peritoneum and skin were closed with two separate 4-0 silk sutures (Ethicon). Upon closure of the incision, mice were woken up by antagonizing medetomidine and midazolam through a subcutaneous cocktail injection of atipamezol (1 mg/kg) and flumazenil (0.25 mg/kg). Mice were allowed to recover on a heating pad, after which they were single-housed. Mice were euthanized after the indicated time points, and liver tissue was obtained. In the peritoneal model, the surgical procedure was as described above, but the peritoneal areas were marked.
To induce adhesions between liver and peritoneum, abrasion and talcum was applied to the electroporated side of the liver and to the opposite side of the peritoneum. In the peritoneal–cecal adhesion model, surfaces of the cecum and peritoneum were injured with a brush, two surgical knots were placed, and talcum powder was applied onto wound sides of both organs. Liver injury was done by electroporation of opposing sites and application of talcum powder. The sterile inflammation model was enacted by locally labeling organ surfaces as described above, and 5 days later repeated injections of sterile lipopolysaccharide in PBS (100 µg/20 g body weight) were performed. To deplete neutrophils, the rat anti-mouse Ly6G monoclonal antibody, clone 1A8 (BioxCell), was injected i.p. 2 days after the i.p. injection of clodronate liposomes (Liposoma). Macrophage depletion was performed with a single i.p. injection of clodronate liposomes. Neutralizing antibodies (Bio X Cell) were applied at a concentration of 200 µg/20 g body weight. CP-105,696 and LY255283 (Sigma Aldrich) were injected i.p. 2 hours before surgery at 10 µM in sterile PBS. Lipoxin (Merck Millipore) was applied locally by soaking the reagent in a sterile filter paper with 100 nM solution and applying the filter paper over the liver surface for 5 minutes. AHA (0.05 mg/g) or HPG (0.025 mg/g) were applied 2 hours prior to surgery and afterwards daily through i.p. injection. Skin wounds were performed according to Correa-Gallegos et al.12.
Human tissue
All human samples were obtained from surgeries at the Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Germany, following approval of the local ethics committee of the Technical University of Munich, Germany (no. 173/18 S). Adhesions were intraoperatively diagnosed and dissected from the respective organs and prepared for further analysis.
Labeling of ECM on organ surfaces
Succinimidyl esters (NHS-esters; Thermo Fisher) were diluted in DMSO to a concentration of 25 mg/ml and stored at −80 °C. To obtain ectopic labeling of matrix, we generated a labeling solution by mixing NHS-ester 1:1 with 100 mM pH 9.0 sodium bicarbonate buffer. Sterile Whatman filter paper (Sigma Aldrich) biopsy punches were soaked in NHS-labeling solution and locally placed on the liver surface. After 1 minute, the labeling punch was removed. For kinetic measurements organ surfaces were marked with a 2-mm filter patch of NHS-FITCproximally (1.0 cm away).
AAV production
Production and purification of AAV preparations for AAVCNA35mCherry was performed according to the AAVpro Purification Kit Maxi (Takara Bio) protocol. In brief, 5× T225-flasks were triple-transfected with the plasmid pHelper from the kit AAVpro Helper Free System (AAV6) (Takara Bio), the plasmid pAAV2/8RGD containing coding sequences of the AAV2-derived rep proteins and the modified AAV8 capsid proteins and the pAAV-Cp-SV40pA derivative containing the AAV genome with the respective transgene. At 96 hours post-transfection, cells were collected and AAV vector particles were released by breaking up the cells with 3× freeze–thaw cycles. Genomic DNA was digested with Cryonase cold-active nuclease, and AAV vector particles were separated from cell debris by filtration (0.45-µm filter). Finally, AAV particles were separated from low molecular contaminants by using 100-kDa size-exclusion columns and were concentrated. Titers of final AAV preparations were determined through qPCR utilizing the AAVpro Titration Kit (qPCR) V2 (Takara Bio). Local AAV labeling was performed using sterile whatman filter papers, as described above.
Tissue preparation
Upon organ excision, organs were fixed overnight at 4 °C in 2% formaldehyde. The next day, fixed tissues were washed three times in Dulbecco’s phosphate buffered saline (DPBS, GIBCO, no. 14190-094), and depending on the purpose, were either embedded, frozen in optimal cutting temperature (OCT) compound (Sakura, no. 4583) and stored at −20 °C, or stored at 4 °C in PBS containing 0.2% gelatin (Sigma Aldrich, no. G1393), 0.5% Triton X-100 (Sigma Aldrich, X100) and 0.01% Thimerosal (Sigma Aldrich, no. T8784) (PBS-GT). Fixed tissues were embedded in OCT compound and cut with a Microm HM 525 (Thermo Scientific) by the standard protocol. In short, sections were fixed in ice-cold acetone for 5 min at −20 °C and then washed with PBS. Sections were then blocked for non-specific binding with 10% serum in PBS for 60 minutes at room temperature, and then incubated with primary antibody in blocking solution overnight at 4 °C. The next day, following washing, sections were incubated in PBS with fluorescent secondary antibody, for 120 minutes at room temperature. Finally, sections were washed and incubated with Hoechst 33342 nucleic acid stain (Invitrogen, no. H1399), washed in ddH2O, mounted with Fluoromount-G (Southern Biotech, no. 0100-01), and stored at 4 °C in the dark.
Primary antibodies were used at 1:100, were from Abcam, and were raised in rabbit unless otherwise stated. Antibodies were raised against the following epitopes: collagen I (1:150, Rockland), collagen 4, fibronectin, HSPG2 (Elabscience), cleaved caspase 3, laminin, hamster anti-PDPN, rat anti-LY6G, TNF, ITGAM, ITGβ2, CD45.2, FPR1, CD62L, YAP, goat anti-PDGFR, TAZ, pSMAD, goat anti-PDGFR, phosphoHSF (Elabscience) and N-cadherin.
Alexa-Fluor-488-, Alexa-Fluor-568- or Alexa-Fluor-647-conjugated antibodies (1:500, Life Technologies) against suitable species were used as secondary antibodies. H&E staining was performed according to the manufacturer’s protocol (Sigma).
Visualization of ncAAs was performed using Alkyne-Alexa Fluor 647 (Thermo Fisher) and Click-iT Cell Reaction Buffer Kit (Thermo Fisher).
Microscopy
Histological sections were imaged under a M205 FCA Stereomicroscope (Leica) and ZEISS AxioImager Z2m (Carl Zeiss). For whole-mount 3D imaging of tissues, fixed samples were embedded in 35-mm glass-bottom dishes (Ibidi) with low-melting-point agarose (Biozym) and left to solidify for 30 min. Imaging was performed with a Leica SP8 multiphoton microscope . For time-lapse imaging of liver and peritoneal tissues, samples were embedded as just above. Imaging medium (DMEM/F-12) was then added. Time-lapse imaging was performed under a M205 FCA Stereomicroscope. A modified incubation system, with heating and gas control (ibidi), was used to guarantee physiologic and stable conditions during imaging. Temperature control was set to 35 °C with 5% CO2-supplemented air. Whole-mount samples for 3D lightsheet imaging were stained and cleared by a modified 3DISCO protocol42. Samples were dehydrated in an ascending tetrahydrofuran (Sigma Aldrich) series (50%, 70%, 3×100%; 60 minutes each), and subsequently cleared in dichloromethane (Sigma Aldrich) for 30 min and then immersed in benzyl ether (Sigma Aldrich). Microscopy samples were kept in cooled, light-protected vials in the dark. Cleared samples were imaged while submerged in benzyl-ether with a lightsheet fluorescence microscope (LaVision BioTec). While submerged in benzyl-ether, specimens were illuminated on two sides by a planar light-sheet using a white-light laser (SuperK Extreme EXW-9; NKT Photonics). Optical sections were recorded by moving the specimen chamber vertically in 5-mm steps through the laser light-sheet. Two-, three- and four-dimensional data were processed with Imaris 9.1.0 (Bitplane) and ImageJ (1.52i). Contrast and brightness were adjusted for better visibility. Overlay channels were generated using Imaris 9.1.0. Quantifications were performed with ImageJ.
Protein biochemistry
Tissues were snap frozen and ground using a tissue lyser (Qiagen). Pulverized tissues were resuspended in lysis buffer (20 mM Tris-HCl pH 7.5, 1% Triton X-100, 2% SDS, 100 mM NaCl, 1 mM sodium orthovanadate, 9.5 mM sodium fluoride, 10 mM sodium pyruvate, 10 mM beta-glycerophosphate), and supplemented with protease inhibitors (complete protease inhibitor cocktail, Pierce) and kept for 10 minutes on ice. Samples were then sonicated and spun down for 5 minutes at 10,000g. Supernatants were stored at −80 °C. Protein concentrations were determined via BCA assay, according to the manufacturer’s protocol (Pierce).
Protein pulldown was as follows. Lysates were diluted with a pulldown buffer (20 mM Tris-HCl pH 7.5, 1% Triton X-100, 100 mM NaCl, supplemented with protease and phosphatase inhibitors) and incubated overnight with dynabeads (Thermo Fisher) according to the manufacturer’s instructions at 4 °C on a rotator. The next day, the samples were each diluted twice with wash buffer 1 (pulldown buffer plus 2% SDS) and then with wash buffer 2 (pulldown buffer with reduced, 0.5% Triton X-100) and were finally washed twice with wash buffer 3 (20 mM Tris-HCl pH 7.5 and 100 mM NaCl). Beads were then resuspended in Elution Buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl and 50 mM DTT) and incubated for 30 minutes at 37 °C. Finally, the samples were boiled for 5 minutes at 98 °C and the supernatants were stored at −80 °C). Lysates for fluorescence measurements were handled in cooled, light protected vials. Fluorescence intensities of lysates were measured in a Fluostar optima fluorometer (BMGlabtechImmunoprecipitation was as previously described43. SDS–PAGE and western blots were performed with the BioRad Wet tank system. Immunoblots were performed via rabbit-anti-GAPDH (1:1,000, Abcam), rabbit-anti-phosphoHSF (1:1,000, Elabscience), rabbit-anti-ITGAM (1:1,000, Abcam) and rabbit-anti-ITGβ2 (1:1,000, Abcam). Anti-rabbit- and anti-rat-HRP was purchased from Biorad and was used at 1:20,000. Quantification of immunoblots was performed using ImageJ.
Mass spectrometry
Tissues were marked locally with an EZ-LINK-NHS 100:1 FITC-NHS mixture. After 24 hours, the organs were removed. Tissue pieces from the original marking were separated from moved matrix fractions and snap frozen. Tissue lysis was performed as described above. Samples were digested by a modified FASP procedure44. After reduction and alkylation using DTT and IAA, the proteins were centrifuged on Microcon centrifugal filters (Sartorius Vivacon 500 30 kDa), washed thrice with 8 M urea in 0.1 M Tris/HCl pH 8.5 and twice with 50 mM ammonium bicarbonate. The proteins on the filter were digested for 2 hours at room temperature using 0.5 µg Lys-C (Wako Chemicals) and for 16 hours at 37 °C with 1 µg trypsin (Promega). Peptides were collected by centrifugation (10 minutes at 14,000g), acidified with 0.5% TFA and stored at −20 °C until measurements. The digested peptides were loaded automatically onto an HPLC system (Thermo Fisher Scientific) equipped with a nano trap column (100 µm ID × 2 cm, Acclaim PepMAP 100 C18, 5 µm, 100 Å/size, LC Packings, Thermo Fisher Scientific) in 95% buffer A (2% ACN, 0.1% formic acid (FA) in HPLC-grade water) and 5% buffer B (98% ACN, 0.1% FA in HPLC-grade water) at 30 µl/min. After 5 min, the peptides were eluted and separated on the analytical column (nanoEase MZ HSS T3 Column, 100 Å, 1.8 µm, 75 µm × 250 mm, Waters) at 250 nl/min flow rate in a 105-minute nonlinear acetonitrile gradient from 3% to 40% in 0.1% formic acid. The eluting peptides were analyzed online in a Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) coupled to the HPLC system with a nano spray ion source and operated in the data-dependent mode. MS spectra were recorded at a resolution of 60,000, and after each MS1 cycle, the 10 most abundant peptide ions were selected for fragmentation. Raw spectra were imported into Progenesis QIsoftware (version 4.1, Nonlinear Dynamics, Waters). After feature alignment and normalization, spectra were exported as Mascot Generic files and searched against the SwissProt mouse database (16,872 sequences) with Mascot (Matrix Science, version 2.6.2) with the following search parameters: 10 ppm peptide mass tolerance and 0.02 Da fragment mass tolerance, two missed cleavages allowed, carbamidomethylation was set as fixed modification, and camthiopropanoyl, methionine and proline oxidation were allowed as variable modifications. A Mascot-integrated decoy database search calculated an average false discovery of <1% when searches were performed with a mascot percolator score cut-off of 13 and an appropriate significance threshold P.
Peptide assignments were re-imported into the Progenesis QI software and the abundances of all unique peptides allocated to each protein were quantified/counted. The resulting normalized abundances of the individual proteins were used for calculation of protein ratios and P values (ANOVA) between sample groups using a nested design. Gene ontology analysis was performed using the EnrichR webtool45,46. Extracellular elements were identified through a database search against a matrisomal database18.
Single-cell RNA-seq
Three livers per experimental group were pooled for each sequencing run. For each liver, the electroporated area was punched out with a circular 4-mm biopsy punch, and subsequently minced with fine scissors into small pieces (approximately 1 mm2). The equivalent but non-injured area was used in control livers. The resulting fragments were further processed by enzymatic digestion in 5 mL enzyme mix consisting of dispase (50 caseinolytic units/ml), collagenase (2 mg/ml), and DNase (30 μg/ml), for 30 minutes at 37 °C under constant agitation (180 rpm). Enzyme activity was inhibited by adding 5 ml of PBS supplemented with 10% FBS. Dissociated cells in suspension were passed through a 70-μm strainer and centrifuged at 500g for 5 minutes at 4 °C. Red blood cell lysis (Thermo Fisher; 00-4333-57) was performed for 2 minutes and stopped with 10% FBS in PBS. After another centrifugation step, the cells were counted in a Neubauer chamber and critically assessed for single-cell separation and viability. A total of 250,000 cells were aliquoted in 2.5 ml of PBS supplemented with 0.04% of BSA and loaded for Drop-seq at a final concentration of 100 cells/μL. Drop-seq experiments were performed as described previously47. In brief, using a microfluidic PDMS device (Nanoshift), single cells were co-encapsulated in droplets with barcoded beads (Chemgenes Corporation) at a final concentration of 120 beads/µL. Droplets were collected for 15 min/sample. After droplet breakage, beads were collected, washed, and prepared for on-bead mRNA reverse transcription (Maxima RT, Thermo Fisher). Following an exonuclease I (New England Biolabs) treatment for the removal of unused primers, beads were counted, aliquoted (2,000 beads/reaction, equals ~100 cells/reaction), and pre-amplified by 13 PCR cycles (primers, chemistry, and cycle conditions identical to those described previously47). PCR products were pooled and purified twice on 0.6× clean-up beads (CleanNA). Prior to tagmentation, cDNA samples were loaded on a DNA High Sensitivity Chip on the 2100 Bioanalyzer (Agilent) to ensure transcript integrity, purity and quantity. For each sample, 1 ng of pre-amplified cDNA from an estimated 1,000 cells was tagmented by Nextera XT (Illumina) with a custom P5 primer (Integrated DNA Technologies). Single-cell libraries were sequenced in a 100-bp paired-end run on an Illumina HiSeq4000 using 0.2 nM denatured sample and 5% PhiX spike-in. For priming of read 1, 0.5 µm Read1CustSeqB was used (primer sequence: GCCTGTCCGCGGAAGCAGTGGTATCAACGCAGAGTAC).
Blood preparation and data analysis for flow cytometry
Murine blood was collected by cardiac puncture and diluted in PBS with heparin. Red blood cells were lysed twice in 1× BD Pharm lysing solution. Antibodies against CD45 and Ly6G were mixed with whole cells together with LIVE/DEAD fixable near-IR dead cell staining dye. Neutrophils were identified as CD45+Ly6G+, excluding doublets and dead cells. Acquisition was performed on BD LSR II (BD) using FACSDiva software (BD), then data were analyzed with FlowJo software (BD, v10.8).
Statistics
Data were analyzed in Prism 7.0.0 (GraphPad). Statistical tests were performed as indicated in the figure legends, and n values are also provided. All error bars represent mean ± s.d. Mice and tissues were randomly assigned to treatment groups where applicable. No data were excluded. Data were presumed to be normally distributed. Statistical significance was defined as P < 0.05, for reasons of space and visibility, the individual P values have not been integrated into the figures.
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41590-022-01166-6.
Supplementary information
Acknowledgements
We thank S. Dietzel and the Core Facility Bioimaging at the Biomedical Centre of the Ludwig-Maximilians Universität München for access and support with the multiphoton system. We thank H. Schiller and M. Stamnitz for access and support for scRNA-seq equipment. Y.R. was supported by the Human Frontier Science Program Career Development Award (CDA00017/2016), the German Research Foundation (RI 2787/1-1 AOBJ: 628819), the Fritz–Thyssen–Stiftung (2016-01277), the Else-Kröner-Fresenius-Stiftung (2016_A21) and the European Research Council Consolidator Grant (ERC-CoG 819933). A. F. was supported by PFP – Helmholtz Postdoctoral Fellowship.
Extended data
Source data
Author contributions
Y.R. supervised the research. A.F., J.W. and Y.R. designed the experiments. A.F. performed animal surgeries with the help of J.W. A.F. designed and performed protein biochemistry experiments. A.F. performed immunofluorescence staining imaging and analysis. H.Y. provided skin tissue samples. A.F. performed stereomicroscope and time-lapse imaging. J.W. provided veterinary advice and prepared animal experiment protocols. S.C. performed multiphoton imaging. T.K. performed single-cell experiments. A.F., C.M. and H.S. visualized mass-spectrometry data. P.-A.N. provided human adhesion samples. S.M.H. and S.K. analyzed mass-spectrometry experiments. M.G. performed light sheet imaging. J.Z. and P.W.K. purified neutrophils. J.Z. performed FACS analysis. P.W.K. and R.F. provided Kindlin3 conditional knockout mice. M.M.-H. designed and produced CNK35 reporter vectors. HGM provided support and assisted in clinical interpretation of the animal data. A.F., T.K. and Y.R. wrote the manuscript.
Peer review
Peer review information
Nature Immunology thanks Derek Mann and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Ioana Visan was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team. Peer reviewer reports are available.
Funding
Open access funding provided by Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH).
Data availability
Source Data for the figures are provided in the individual source file. Raw files of mass-spectrometry experiments are available at PRIDE accession code: PXD031766. RNA-sequencing datasets generated in this paper are available under GEO accession code: GSE198828. Source data are provided with this paper.
Code availability
Code used for Massspec processing is available at: https://github.com/kadrisaf/Fluid_Matrix
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Adrian Fischer, Juliane Wannemacher, Simon Christ.
Extended data
is available for this paper at 10.1038/s41590-022-01166-6.
Supplementary information
The online version contains supplementary material available at 10.1038/s41590-022-01166-6.
References
- 1.Eming, S. A., Martin, P. & Tomic-Canic, M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci. Transl. Med. 6, 265sr6 (2014). [DOI] [PMC free article] [PubMed]
- 2.Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J. 2017;8:23–33. doi: 10.1007/s13167-017-0081-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Guo S, DiPietro LA. Critical review in oral biology & medicine: factors affecting wound healing. J. Dent. Res. 2010;89:219–229. doi: 10.1177/0022034509359125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nussbaum SR, et al. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing. Wounds Value Heal. 2018;21:27–32. doi: 10.1016/j.jval.2017.07.007. [DOI] [PubMed] [Google Scholar]
- 5.Shetty, A. & Syn, W. Health and economic burden of nonalcoholic fatty liver disease in the united states and its impact on veterans. Fed. Pract.36, 14–19 (2019). [PMC free article] [PubMed]
- 6.Agata K, Saito Y, Nakajima E. Unifying principles of regeneration I: epimorphosis versus morphallaxis. Dev. Growth Differ. 2007;49:73–78. doi: 10.1111/j.1440-169X.2007.00919.x. [DOI] [PubMed] [Google Scholar]
- 7.Iismaa SE, et al. Comparative regenerative mechanisms across different mammalian tissues. Regen. Med. 2018;3:1–20. doi: 10.1038/s41536-018-0044-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Maxson, Mitchell Regenerative tissue remodeling in planarians — the mysteries of morphallaxis. Physiol. Behav. 2016;176:139–148. [Google Scholar]
- 9.Flanagan M. The characteristics and formation of granulation tissue. J. Wound Care. 1998;7:508–510. doi: 10.12968/jowc.1998.7.10.508. [DOI] [PubMed] [Google Scholar]
- 10.Hinz B. The role of myofibroblasts in wound healing. Curr. Res. Transl. Med. 2016;64:171–177. doi: 10.1016/j.retram.2016.09.003. [DOI] [PubMed] [Google Scholar]
- 11.Schürch, W., Seemayer, T. A. & Gabbiani, G. The myofibroblast: a quarter century after its discovery. Am. J. Surg. Pathol. 22, 141–147 (1998). [DOI] [PubMed]
- 12.Correa-Gallegos D, et al. Patch repair of deep wounds by mobilized fascia. Nature. 2019;576:287–292. doi: 10.1038/s41586-019-1794-y. [DOI] [PubMed] [Google Scholar]
- 13.Wagstaff PGK, et al. Irreversible electroporation: state of the art. Onco. Targets Ther. 2016;9:2437–2446. doi: 10.2147/OTT.S88086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lee EW, Thai S, Kee ST. Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver. 2010;4:99–104. doi: 10.5009/gnl.2010.4.S1.S99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Golberg A, Bruinsma BG, Jaramillo M, Yarmush ML, Uygun BE. Rat liver regeneration following ablation with irreversible electroporation. PeerJ. 2016;2016:1–17. doi: 10.7717/peerj.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Calve S, Witten AJ, Ocken AR, Kinzer-Ursem TL. Incorporation of non-canonical amino acids into the developing murine proteome. Sci. Rep. 2016;6:1–7. doi: 10.1038/srep32377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Schiller, H. B. et al. Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair. Mol. Syst. Biol.11, 819 (2015). [DOI] [PMC free article] [PubMed]
- 18.Shao X, Taha IN, Clauser KR, Gao YT, Naba A. MatrisomeDB: the ECM-protein knowledge database. Nucleic Acids Res. 2020;48:D1136–D1144. doi: 10.1093/nar/gkz849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Boerboom RA, et al. High resolution imaging of collagen organisation and synthesis using a versatile collagen specific probe. J. Struct. Biol. 2007;159:392–399. doi: 10.1016/j.jsb.2007.04.008. [DOI] [PubMed] [Google Scholar]
- 20.Jiang, D. et al. Injury triggers fascia fibroblast collective cell migration to drive scar formation through N-cadherin. Nat. Commun. 11, 5653 (2020). [DOI] [PMC free article] [PubMed]
- 21.Miyazaki S, Ishikawa F, Fujikawa T, Nagata S, Yamaguchi K. Intraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr-1high polymorphonuclear neutrophils in the murine abdominal cavity. Clin. Diagn. Lab. Immunol. 2004;11:452–457. doi: 10.1128/CDLI.11.3.452-457.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Garcia-Touchard A, et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler. Thromb. Vasc. Biol. 2005;25:1119–1127. doi: 10.1161/01.ATV.0000164311.48592.da. [DOI] [PubMed] [Google Scholar]
- 23.Yamakoshi, Y. Dental and Oral Biology, Biochemistry. Reference Module in Biomedical Sciences (Elsevier, 2014).
- 24.Curaj, A. et al. Neutrophils modulate fibroblast function and promote healing and scar formation after murine myocardial infarction. Int. J. Mol. Sci. 21, 3685 (2020). [DOI] [PMC free article] [PubMed]
- 25.Daseke MJ, et al. Neutrophil proteome shifts over the myocardial infarction time continuum. Basic Res. Cardiol. 2019;114:1–13. doi: 10.1007/s00395-019-0746-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lämmermann T, et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature. 2013;498:371–375. doi: 10.1038/nature12175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang G, et al. Oxidant sensing by TRPM2 inhibits neutrophil migration and mitigates inflammation. Dev. Cell. 2016;38:453–462. doi: 10.1016/j.devcel.2016.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ruppert R, et al. Kindlin-3-mediated integrin adhesion is dispensable for quiescent but essential for activated hematopoietic stem cells. J. Exp. Med. 2015;212:1415–1432. doi: 10.1084/jem.20150269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Krenn PW, Koschmieder S, Fässler R. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches. Proc. Natl Acad. Sci. USA. 2020;117:24326–24335. doi: 10.1073/pnas.2009078117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zhang X, Zhang X, Huang W, Ge X. The role of heat shock proteins in the regulation of fibrotic diseases. Biomed. Pharmacother. 2021;135:111067. doi: 10.1016/j.biopha.2020.111067. [DOI] [PubMed] [Google Scholar]
- 31.Bellaye PS, Burgy O, Causse S, Garrido C, Bonniaud P. Heat shock proteins in fibrosis and wound healing: good or evil? Pharmacol. Ther. 2014;143:119–132. doi: 10.1016/j.pharmthera.2014.02.009. [DOI] [PubMed] [Google Scholar]
- 32.Åkerfelt M, Morimoto RI, Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 2010;11:545–555. doi: 10.1038/nrm2938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kechagia JZ, Ivaska J, Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat. Rev. Mol. Cell Biol. 2019;20:457–473. doi: 10.1038/s41580-019-0134-2. [DOI] [PubMed] [Google Scholar]
- 34.Herrera J, Henke CA, Bitterman PB. Extracellular matrix as a driver of progressive fibrosis. J. Clin. Invest. 2018;128:45–53. doi: 10.1172/JCI93557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Stepensky PY, et al. Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation. J. Pediatr. Hematol. Oncol. 2015;37:264–268. doi: 10.1097/MPH.0000000000000228. [DOI] [PubMed] [Google Scholar]
- 36.Tsai JM, et al. Neutrophil and monocyte kinetics play critical roles in mouse peritoneal adhesion formation. Blood Adv. 2019;3:2713–2721. doi: 10.1182/bloodadvances.2018024026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Silvestre-Roig C, Fridlender ZG, Glogauer M, Scapini P. Neutrophil diversity in health and disease. Trends Immunol. 2019;40:565–583. doi: 10.1016/j.it.2019.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rosales C. Neutrophil: a cell with many roles in inflammation or several cell types? Front. Physiol. 2018;9:1–17. doi: 10.3389/fphys.2018.00113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Park AM, et al. Heat shock protein 27 plays a pivotal role in myofibroblast differentiation and in the development of bleomycin-induced pulmonary fibrosis. PLoS ONE. 2016;11:1–15. doi: 10.1371/journal.pone.0148998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Scheraga RG, et al. Activation of heat shock response augments fibroblast growth factor-1 expression in wounded lung epithelium. Am. J. Physiol. 2016;311:L941–L955. doi: 10.1152/ajplung.00262.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Tomcik M, et al. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis. Ann. Rheum. Dis. 2014;73:1215–1222. doi: 10.1136/annrheumdis-2012-203095. [DOI] [PubMed] [Google Scholar]
- 42.Ertürk A, et al. Three-dimensional imaging of solvent-cleared organs using 3DISCO. Nat. Protoc. 2012;7:1983–1995. doi: 10.1038/nprot.2012.119. [DOI] [PubMed] [Google Scholar]
- 43.Fischer, A., Mühlhäuser, W. W. D., Warscheid, B. & Radziwill, G. Membrane localization of acetylated CNK1 mediates a positive feedback on RAF/ERK signaling. Sci. Adv. 3, e1700475 (2017). [DOI] [PMC free article] [PubMed]
- 44.Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat. Methods. 2009;6:359–362. doi: 10.1038/nmeth.1322. [DOI] [PubMed] [Google Scholar]
- 45.Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics14, 128 (2013). [DOI] [PMC free article] [PubMed]
- 46.Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90–W97. doi: 10.1093/nar/gkw377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Macosko EZ, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161:1202–1214. doi: 10.1016/j.cell.2015.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Source Data for the figures are provided in the individual source file. Raw files of mass-spectrometry experiments are available at PRIDE accession code: PXD031766. RNA-sequencing datasets generated in this paper are available under GEO accession code: GSE198828. Source data are provided with this paper.
Code used for Massspec processing is available at: https://github.com/kadrisaf/Fluid_Matrix